safety, pharmacokinetics and pharmacodynamics study of HL-032 in healthy male volunteers
Not Applicable
Recruiting
- Conditions
- Not Applicable
- Registration Number
- KCT0000197
- Lead Sponsor
- Hanall Biopharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
1) Healthy male, Age 10 to 50
2) Subject must be willing and able to provide written informed consent to the study
Exclusion Criteria
1) Known hypersensitivity to octreotid or hGH
2) History of any siginificant Sickness, Cardiovascular, Respiratory, Renal, Endocrine, Neurological, Psychic, Cancer, Gastrointestinal, Hematologic
3) History of drug and/or alcohol abuse
4) Over 10 tobaccos a day
5) Other condition which in the opinion of the investigator preclude enrollment into the study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Area under the serum hGH(human growth hormone)concentration-time curve;Maximum observed serum hGH(human growth hormone)concentration
- Secondary Outcome Measures
Name Time Method Area under the effect(IGF-1, IGFBP-3, NEFA )curve;Maximum IGF-1, IGFBP-3, NEFA concentration